This transaction is expected to close in the third quarter of 2009 and is subject to customary government approvals, the finalization of certain ancillary agreements and the disclosure schedules, as well as other customary conditions.
Morgan Stanley is acting as financial advisor and Latham & Watkins, LLP is serving as legal counsel to Beckman Coulter in connection with this transaction.
Investor Webcast Event
Beckman Coulter will host a webcast on Friday, February 27, 2009 at 5:00 AM Pacific time to discuss the transaction. The audio portion of the event may be accessed by dialing (877) 516-3365 or (706) 679-3246 and asking for the Beckman Coulter conference call or reservation #87537521.
To participate via the website and obtain access to the presentation materials, please go to Beckman Coulter's website at www.beckmancoulter.com and select "go to IR" under Investor Relations and find the call listed under "What's Ahead." The webcast will be archived for future on-demand replay.
About Beckman Coulter
Beckman Coulter, Inc., based in Fullerton, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of consumable supplies, (including reagent test k
|SOURCE Beckman Coulter, Inc.|
Copyright©2009 PR Newswire.
All rights reserved